🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We're proud to honor the incredible women who make up 75% of our workforce! From the labs to production zone and executive committee, these women are driving innovation, and making a real difference in the fight against biological threats! #InternationalWomensDay2024

📢Fabentech is glad to attend the Conference in Strasbourg! Véronique Juillard, Fabentech’s Scientific Director, will take the stage and present our technology and how it offers a multifaceted shield against emerging biothreats. 🤝We are eager to meet you at there!

Fabentech invites prospective partners to engage on Investor Day, March, 20th! Sébastien IVA, Fabentech CEO, will be present : this is the opportunity to discover more about Fabentech’s ambitious vision, products and cutting-edge technology.

👉Fabentech se rend à #GLOBALINDUSTRIE, le rendez-vous business des acteurs de l’industrie d’aujourd’hui et de demain ! 🎙️Sébastien Iva a notamment pris la parole pour évoquer le sujet crucial de l’industrie du #biomédicament comme facteur de #souveraineté #NRBC #GI24

🔬 Fabentech au Forum Labo de Lyon : une journée riche en nouvelles perspectives ! Nous avons : 🔎 découvert les dernières avancées technologiques 🤝 consolidé nos liens avec nos fournisseurs 💬 échangé avec des acteurs clés du secteur Plus d'infos : forumlabo.com/lyon/fr-fr.html

Découvrez l’intervention de Sébastien Iva, CEO de Fabentech, au Global Industrie. A retenir: 👉 notre ambition de devenir le leader européen des immunothérapies d’urgence 👉le besoin d’un bouclier européen et souverain contre les menaces biologiques youtube.com/watch?v=cZi6-l…

Fabentech stands ready to deploy FabenFLU®, a fully-developed treatment designed to combat potential epidemics from the #AvianFlu virus. FabenFLU® showed broad neutralizing activity against a vast range of 20 virus clades, reinforcing the potency of polyclonal approach.

✨ Sébastien Iva will attend the EU HERA Info Days, and represent Fabentech expertise and ambition together with stakeholders of #healthpreparedness and response in Europe ! 🗓 April, 18th 2024 📍Paris, France More about the HERA Info Days : lnkd.in/gH3vTsJX

💊 Fabentech was present at the launch of the Critical Medicines Alliance, a pioneering initiative! We're dedicated to contributing to this essential cause, collaborating closely with European stakeholders to strengthen health security and resilience against #biologicalthreats.

WHO publishes the Bacterial Priority Pathogens List, incl. 15 families of antibiotic resistant pathogens, grouped into categories of priority for R&D. HERA's glad to support World Health Organization (WHO) for this prioritisation work, guiding 🌍 R&D and investment against #AMR 👉shorturl.at/BFhRB

🤝 Ready to connect and discover more about Fabentech lifesaving solutions against biological threats? Come and meet Sébastien IVA, CEO, and Grégory Vernier, Ph.D., Head of Business Development, who will attend the BIO International Convention in San Diego from June 3th to 6th!

Great discussion on health preparedness at NATO HQ today! Head of HERA Gone with the Wind had a productive exchange with NATO officials. A pleasure to see Dr Raed Arafat again! Together, we're better prepared to tackle global health challenges #NATO #HealthPreparedness #HERA

📢 Great achievement! Fabentech is thrilled to announce the launch and first results of first-in-human clinical trial for a antidote against a deadly plant-based toxin! 🔎To discover more about this exciting news, visit our linkedin post 👇: linkedin.com/posts/fab%27en…

🎙️Great presentation of Caroline Ballet at the 6th Edition of the #WorldCongressOnInfectiousDiseases! Caroline took the stage and shared the findings of Epic Crown 2 project. These results demonstrate the broadly neutralizing activity of #polyclonalantibody fragments.

📢@Fabentech is thrilled to announce it will receive €20 million in financing to advance #Preparedness against #BiologicalThreats, allocated by the European Investment Bank European Investment Bank through the EU HERA Invest programme! Read our press release at fabentech.com/en/french-biop…

Thanks EU HERA and European Investment Bank for your trust and support in helping us to combat biological threats.

1st #HERAInvest Ioan signed with Fabentech & European Investment Bank to advance the development of broad-spectrum therapeutics against cross-border health threats. A vital step in fostering innovation & preparedness for public health emergencies with a €20M investment ➡️🔗europa.eu/!78TRDb

🇫🇷🇪🇺 Investing in innovative biotech companies is essential to strengthen health security in Europe. We are joining forces with EU HERA and French biopharmaceutical company Fabentech to advance preparedness against pandemics and biological threats⤵️ bit.ly/Fabentech

Nous signons aujourd'hui via EU HERA & European Investment Bank un accord HERA Invest d'une valeur de 20 M€ avec @Fabentech 🇫🇷 Il permettra à l'entreprise de mettre au point & déployer ses médicaments à large spectre afin de lutter contre les menaces biologiques pour la santé publique 🔬

🎙️Sébastien IVA était invité sur le plateau de BFM Lyon à l’occasion de l’obtention d’un financement de 20 millions d’euros accordé par la Banque Européenne d’Investissement, via le mécanisme HERA Invest. European Investment Bank EU HERA 👇👇 Replay à 2min41 lnkd.in/dnbvWjyA